CPT 82040: Quantitative Albumin Measurement
Commercial payers pay $10 on average nationally for this procedure.
CPT code 82040 describes a quantitative albumin measurement performed by a laboratory analyst on a serum, plasma, or whole blood specimen; this is a clinical laboratory service typically provided in an outpatient or hospital laboratory setting for evaluation of protein status and liver or renal function.
For related coverage guidance, see recent payer policy updates: Diabetic Supplies, Radiofrequency Ablation for Thyroid Nodules, Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes (for Idaho Only).
Customize your policy alerts
Sign up for cpt 82040 policy alerts
Get alerted when payer policies referencing 82040 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
The national commercial average represented by BUCA sits at $10.4 for CPT 82040, framing the market midline while individual payer patterns vary. Blue Cross Blue Shield shows a relatively wide spread between its 25th and 75th percentiles ($7.40 to $16.90), a P75–P25 range of $9.50, and Aetna presents an even broader dispersion from $3.00 to $6.90 (range $3.90) but with extreme outliers up to $514.90. Cigna and UnitedHealth Group exhibit tighter interquartile spreads—Cigna’s P25–P75 runs $3.30 to $7.10 (range $3.80) and UnitedHealth Group’s $2.10 to $5.00 (range $2.90)—indicating more consistent negotiated commercial rates.
Comparatively, Blue Cross Blue Shield and Aetna demonstrate the widest variability in the middle 50% of their commercial reimbursements, while UnitedHealth Group and Cigna are the tightest. BUCA’s mean of $10.4 functions as a practical market benchmark against which those payer dispersions can be viewed; payers with narrow interquartile ranges suggest greater pricing consistency, while wider ranges point to greater regional or contractual variability.